Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 13:23:09 UTC
Update Date2021-09-26 23:08:01 UTC
HMDB IDHMDB0254194
Secondary Accession NumbersNone
Metabolite Identification
Common NameLucitanib
DescriptionLucitanib, also known as e-3810 amine, belongs to the class of organic compounds known as naphthalenecarboxamides. Naphthalenecarboxamides are compounds containing a naphthalene moiety, which bears a carboxylic acid amide group at one or more positions. Naphthalene is a bicyclic compound that is made up of two fused benzene rings. Based on a literature review a significant number of articles have been published on Lucitanib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Lucitanib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Lucitanib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
e-3810 AmineChEBI
e-3810co-3810S 80881AL-3810lucitanibChEMBL
Chemical FormulaC26H25N3O4
Average Molecular Weight443.503
Monoisotopic Molecular Weight443.184506297
IUPAC Name6-({7-[(1-aminocyclopropyl)methoxy]-6-methoxyquinolin-4-yl}oxy)-N-methylnaphthalene-1-carboxamide
Traditional Name6-({7-[(1-aminocyclopropyl)methoxy]-6-methoxyquinolin-4-yl}oxy)-N-methylnaphthalene-1-carboxamide
CAS Registry NumberNot Available
SMILES
CNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C1
InChI Identifier
InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)
InChI KeyCUDVHEFYRIWYQD-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as naphthalenecarboxamides. Naphthalenecarboxamides are compounds containing a naphthalene moiety, which bears a carboxylic acid amide group at one or more positions. Naphthalene is a bicyclic compound that is made up of two fused benzene rings.
KingdomOrganic compounds
Super ClassBenzenoids
ClassNaphthalenes
Sub ClassNaphthalenecarboxylic acids and derivatives
Direct ParentNaphthalenecarboxamides
Alternative Parents
Substituents
  • 1-naphthalenecarboxamide
  • Diaryl ether
  • Quinoline
  • Anisole
  • Alkyl aryl ether
  • Pyridine
  • Heteroaromatic compound
  • Amino acid or derivatives
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Carboxylic acid derivative
  • Ether
  • Azacycle
  • Organoheterocyclic compound
  • Organic oxygen compound
  • Primary aliphatic amine
  • Amine
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Organic oxide
  • Organonitrogen compound
  • Organooxygen compound
  • Primary amine
  • Organopnictogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.24ALOGPS
logP2.97ChemAxon
logS-5.5ALOGPS
pKa (Strongest Acidic)15.34ChemAxon
pKa (Strongest Basic)9.39ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area95.7 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity124.62 m³·mol⁻¹ChemAxon
Polarizability47.84 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+209.57230932474
DeepCCS[M-H]-207.21530932474
DeepCCS[M-2H]-240.130932474
DeepCCS[M+Na]+215.66630932474
AllCCS[M+H]+209.332859911
AllCCS[M+H-H2O]+207.132859911
AllCCS[M+NH4]+211.332859911
AllCCS[M+Na]+211.932859911
AllCCS[M-H]-204.832859911
AllCCS[M+Na-2H]-205.032859911
AllCCS[M+HCOO]-205.432859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
LucitanibCNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C15388.8Standard polar33892256
LucitanibCNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C14006.8Standard non polar33892256
LucitanibCNC(=O)C1=C2C=CC(OC3=C4C=C(OC)C(OCC5(N)CC5)=CC4=NC=C3)=CC2=CC=C14287.8Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Lucitanib,1TMS,isomer #1CNC(=O)C1=CC=CC2=CC(OC3=CC=NC4=CC(OCC5(N[Si](C)(C)C)CC5)=C(OC)C=C34)=CC=C124140.1Semi standard non polar33892256
Lucitanib,1TMS,isomer #1CNC(=O)C1=CC=CC2=CC(OC3=CC=NC4=CC(OCC5(N[Si](C)(C)C)CC5)=C(OC)C=C34)=CC=C124143.2Standard non polar33892256
Lucitanib,1TMS,isomer #1CNC(=O)C1=CC=CC2=CC(OC3=CC=NC4=CC(OCC5(N[Si](C)(C)C)CC5)=C(OC)C=C34)=CC=C125601.1Standard polar33892256
Lucitanib,1TMS,isomer #2COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N)CC14102.2Semi standard non polar33892256
Lucitanib,1TMS,isomer #2COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N)CC13980.3Standard non polar33892256
Lucitanib,1TMS,isomer #2COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N)CC15594.6Standard polar33892256
Lucitanib,2TMS,isomer #1COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N[Si](C)(C)C)CC14071.1Semi standard non polar33892256
Lucitanib,2TMS,isomer #1COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N[Si](C)(C)C)CC14105.5Standard non polar33892256
Lucitanib,2TMS,isomer #1COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N[Si](C)(C)C)CC15142.2Standard polar33892256
Lucitanib,2TMS,isomer #2CNC(=O)C1=CC=CC2=CC(OC3=CC=NC4=CC(OCC5(N([Si](C)(C)C)[Si](C)(C)C)CC5)=C(OC)C=C34)=CC=C124209.6Semi standard non polar33892256
Lucitanib,2TMS,isomer #2CNC(=O)C1=CC=CC2=CC(OC3=CC=NC4=CC(OCC5(N([Si](C)(C)C)[Si](C)(C)C)CC5)=C(OC)C=C34)=CC=C124213.6Standard non polar33892256
Lucitanib,2TMS,isomer #2CNC(=O)C1=CC=CC2=CC(OC3=CC=NC4=CC(OCC5(N([Si](C)(C)C)[Si](C)(C)C)CC5)=C(OC)C=C34)=CC=C125416.4Standard polar33892256
Lucitanib,3TMS,isomer #1COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N([Si](C)(C)C)[Si](C)(C)C)CC14160.6Semi standard non polar33892256
Lucitanib,3TMS,isomer #1COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N([Si](C)(C)C)[Si](C)(C)C)CC14143.0Standard non polar33892256
Lucitanib,3TMS,isomer #1COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N([Si](C)(C)C)[Si](C)(C)C)CC15000.9Standard polar33892256
Lucitanib,1TBDMS,isomer #1CNC(=O)C1=CC=CC2=CC(OC3=CC=NC4=CC(OCC5(N[Si](C)(C)C(C)(C)C)CC5)=C(OC)C=C34)=CC=C124371.3Semi standard non polar33892256
Lucitanib,1TBDMS,isomer #1CNC(=O)C1=CC=CC2=CC(OC3=CC=NC4=CC(OCC5(N[Si](C)(C)C(C)(C)C)CC5)=C(OC)C=C34)=CC=C124303.2Standard non polar33892256
Lucitanib,1TBDMS,isomer #1CNC(=O)C1=CC=CC2=CC(OC3=CC=NC4=CC(OCC5(N[Si](C)(C)C(C)(C)C)CC5)=C(OC)C=C34)=CC=C125463.8Standard polar33892256
Lucitanib,1TBDMS,isomer #2COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C(C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N)CC14330.7Semi standard non polar33892256
Lucitanib,1TBDMS,isomer #2COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C(C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N)CC14143.6Standard non polar33892256
Lucitanib,1TBDMS,isomer #2COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C(C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N)CC15568.0Standard polar33892256
Lucitanib,2TBDMS,isomer #1COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C(C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N[Si](C)(C)C(C)(C)C)CC14513.7Semi standard non polar33892256
Lucitanib,2TBDMS,isomer #1COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C(C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N[Si](C)(C)C(C)(C)C)CC14387.6Standard non polar33892256
Lucitanib,2TBDMS,isomer #1COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C(C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N[Si](C)(C)C(C)(C)C)CC15099.6Standard polar33892256
Lucitanib,2TBDMS,isomer #2CNC(=O)C1=CC=CC2=CC(OC3=CC=NC4=CC(OCC5(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC5)=C(OC)C=C34)=CC=C124677.2Semi standard non polar33892256
Lucitanib,2TBDMS,isomer #2CNC(=O)C1=CC=CC2=CC(OC3=CC=NC4=CC(OCC5(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC5)=C(OC)C=C34)=CC=C124517.9Standard non polar33892256
Lucitanib,2TBDMS,isomer #2CNC(=O)C1=CC=CC2=CC(OC3=CC=NC4=CC(OCC5(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC5)=C(OC)C=C34)=CC=C125201.0Standard polar33892256
Lucitanib,3TBDMS,isomer #1COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C(C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC14821.9Semi standard non polar33892256
Lucitanib,3TBDMS,isomer #1COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C(C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC14528.9Standard non polar33892256
Lucitanib,3TBDMS,isomer #1COC1=CC2=C(OC3=CC=C4C(C(=O)N(C)[Si](C)(C)C(C)(C)C)=CC=CC4=C3)C=CN=C2C=C1OCC1(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)CC14955.5Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Lucitanib GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a4i-9112200000-77db1094e8931209f0dc2021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Lucitanib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lucitanib 10V, Positive-QTOFsplash10-0006-1001900000-5933076fd73f4b481d4e2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lucitanib 20V, Positive-QTOFsplash10-05fu-9323600000-9190f96785f9a724c5522017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lucitanib 40V, Positive-QTOFsplash10-0umi-9804000000-ad7e7513166972f927902017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lucitanib 10V, Negative-QTOFsplash10-0006-0011900000-7f8df8ecccd5600ff3e92017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lucitanib 20V, Negative-QTOFsplash10-0596-2026900000-c4821c15eb56659cb8ab2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lucitanib 40V, Negative-QTOFsplash10-0k96-6689000000-e32a4350d69bac2de3f22017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lucitanib 10V, Positive-QTOFsplash10-0006-0003900000-8dbae27a681f93a93a7e2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lucitanib 20V, Positive-QTOFsplash10-01vn-0009500000-2f221397418bca7020c02021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lucitanib 40V, Positive-QTOFsplash10-014i-1209100000-ddb95fd561abbd0bcce42021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lucitanib 10V, Negative-QTOFsplash10-0006-0001900000-baac7c12174f16669f7e2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lucitanib 20V, Negative-QTOFsplash10-02fx-0009300000-30f64acdf515a66b67232021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Lucitanib 40V, Negative-QTOFsplash10-0006-2309200000-855b7f6e1b0740d036c32021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB11845
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID28189586
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkLucitanib
METLIN IDNot Available
PubChem Compound25031915
PDB IDNot Available
ChEBI ID65209
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]